Peanut allergies may soon be a concern of the past

By February 3, 2014Asthma

Although new cases of peanut allergies are on the rise, that might be a concern of the past, as scientists believe they might have found a solution resume form word.
Even though it’s not a cure, scientists have developed a new system that will help build-up tolerance to peanut allergies. This revolutionary test is a form of immunotherapy, and involves patients between the ages of 9 and 16 who are exposed to small doses of peanuts, over a long period of time.

The amount used in the initial stage is about one 70th of a peanut. The dosage is increased by small amounts over time, to improve the level of tolerance. By the end of the trial, some patients were able to eat up to 5 peanuts in one sitting, which is considered to be a remarkable success.

The process however can take years, and may pose significant health risks during the initial stage. At the start of the immunotherapy, patients remain at a clinic in case of an emergency. Once their tolerance levels have improved, they can continue with the therapy at home, under adult supervision.

The success of the immunotherapy gives hope to many families who live in constant fear of an allergic reaction (anaphylactic shock.) This severe reaction to a peanut allergy can be lethal if it’s not treated immediately. It’s also the reason why many sufferers are made to carry an EpiPen, an auto-injector that administers a dose of adrenaline (epinephrine) into the bloodstream, to instantly treat anaphylaxis.

Patients involved in the trial won’t be fully immune to the effects of a peanut allergy, but it will help manage the condition and prevent future accidents from occurring.

Read  Are we curing HIV with stem-cells?

To find out more about this revolutionary trial, here’s the original news story: